Repositorio
Institucional

Mente, Andrew

Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries

AMER MEDICAL ASSOC

JAMA INTERNAL MEDICINE

en

artículo original

acceso abierto

Dr S. Yusuf is supported by the MarionWBurke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: This study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de La Frontera [DI13-PE11], China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grants 100-IRDC/BIOTEK 16/6/21 [13/2007] and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant 290/W-PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Dr.Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University (Research group RG -1436-013), Riyadh, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University, Makkah, Saudi Arabia, South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: Grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life andWelfare, King Gustaf V's and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.

10.1001/jamainternmed.2021.0036

pdf

Medicina general e interna

Medicina General e Interna

WOS:000627902500001

acceso abierto

acceso abierto

Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries

artículo original

version publicada

AMER MEDICAL ASSOC

JAMA INTERNAL MEDICINE

Medicina general e interna

en

2168-6106

Dr S. Yusuf is supported by the MarionWBurke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: This study was supported by an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de La Frontera [DI13-PE11], China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grants 100-IRDC/BIOTEK 16/6/21 [13/2007] and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant 290/W-PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Dr.Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University (Research group RG -1436-013), Riyadh, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University, Makkah, Saudi Arabia, South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: Grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life andWelfare, King Gustaf V's and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.

UFRO DI13-PE11

Colciencias 6566-04-18062

Colciencias 6517-777-58228

MOSTI 100-IRDC/BIOTEK 16/6/21 [13/2007]

MOSTI 07-05-IFN-BPH 010

MOSTI 600-RMI/LRGS/5/3 2/2011

UKM Hejim-Komuniti-15-2010

NAUKA 290/W-PURE/2008/0

KSU RG -1436-013

dorada

pdf